Janos Pitlik;Robert B. Perni;Kevin M. Cottrell;Wayne C. Schairer
发明人:
Kevin M. Cottrell,Robert B. Perni,Janos Pitlik,Wayne C. Schairer
申请号：
US12265125
公开号：
US08426359B2
申请日:
2008.11.05
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to compounds of formula I:or a pharmaceutically acceptable salts thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are useful as antiviral agents. The invention further relates to pharmaceutically acceptable compositions comprising said compounds either for ex vivo use or for administration to a patient suffering from HCV infection and to processes for preparing the compounds. The invention also relates to methods of treating an HCV infection in a patient by administering a pharmaceutical composition comprising a compound of this invention.
